IMA Clinical Research

IMA Clinical Research operates one of the largest flexible clinical trial site networks in the US. They provide access to diverse patient populations through over a dozen full-service sites and more than one hundred satellite locations. Their services enable sponsors and CROs to accelerate enrollment and improve data quality for new medical treatments across multiple therapeutic areas. As a service provider/CRO, they do not have proprietary drug programs or clinical results. They are recognized for their ability to reach underserved populations via hybrid/decentralized models. No direct pipeline of therapeutics—pipeline breadth/pipeline fields below reflect this. Recent growth includes several acquisitions expanding their national footprint. Key leadership includes Dr. Mark Weinberger (President & CEO), Michael Minor (Executive Advisor), David C. Pulver MD (Executive Chairman/Founder of The IMA Group).